Background Patients with left ventricular assist devices (LVADs) are at increased risk of GI bleeding (GIB), primarily from GI angiodysplastic lesions (GIAD). Objective To perform meta …
Flowing blood exerts a frictional force, fluid shear stress (FSS), on the endothelial cells that line the blood and lymphatic vessels. The magnitude, pulsatility, and directional …
A Kilic, MA Acker, P Atluri - Journal of thoracic disease, 2015 - ncbi.nlm.nih.gov
Left ventricular assist devices (LVAD) will undoubtedly have an increasing role due to the aging population, anticipated concomitant increase in the prevalence of end-stage heart …
Objectives Bleeding is an important source of morbidity in patients with a left ventricular assist device. Evidence suggests a major role for von Willebrand factor. However, limited …
L Harvey, CT Holley, R John - Annals of cardiothoracic surgery, 2014 - ncbi.nlm.nih.gov
Background Continuous-flow left ventricular assist devices (CF-LVADs) have become the standard of care for patients with end-stage heart failure (HF). While these devices have …
J Kang, S Hennessy-Strahs, P Kwiatkowski… - Circulation …, 2017 - Am Heart Assoc
Rationale: The objective of this autopsy study was to determine whether gastrointestinal angiodysplasia develops during continuous-flow left ventricular assist device (LVAD) …
DJ Goldstein, KD Aaronson, AJ Tatooles, SC Silvestry… - JACC: Heart Failure, 2015 - jacc.org
Objectives: This study evaluated gastrointestinal bleeding (GIB) in patients receiving the HeartWare HVAD System (HeartWare Inc., Framingham, Massachusetts) in the pivotal BTT …
K Cushing, V Kushnir - Digestive diseases and sciences, 2016 - Springer
Background Left ventricular assist devices (LVADs) are an increasingly prevalent form of mechanical support for patients with end-stage heart failure. These devices can be …
Chronic heart failure (HF) is a major emerging healthcare problem, associated with a high morbidity and mortality. Left ventricular assist devices (LVADs) have emerged as a …